A detailed history of Riggs Asset Managment Co. Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Riggs Asset Managment Co. Inc. holds 3,067 shares of LLY stock, worth $2.44 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
3,067
Previous 3,073 0.2%
Holding current value
$2.44 Million
Previous $2.78 Million 2.34%
% of portfolio
0.76%
Previous 0.83%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$772.14 - $960.02 $4,632 - $5,760
-6 Reduced 0.2%
3,067 $2.72 Million
Q2 2024

Jul 29, 2024

SELL
$724.87 - $909.04 $17,396 - $21,816
-24 Reduced 0.77%
3,073 $2.78 Million
Q1 2024

May 03, 2024

SELL
$592.2 - $792.28 $79,354 - $106,165
-134 Reduced 4.15%
3,097 $2.41 Million
Q4 2023

Jan 31, 2024

BUY
$525.19 - $619.13 $455,864 - $537,404
868 Added 36.73%
3,231 $1.88 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $1,304 - $1,797
3 Added 0.13%
2,363 $1.27 Million
Q2 2023

Jul 21, 2023

BUY
$350.74 - $468.98 $764,963 - $1.02 Million
2,181 Added 1218.44%
2,360 $1.11 Million
Q1 2023

May 09, 2023

BUY
$310.63 - $364.82 $18,637 - $21,889
60 Added 50.42%
179 $61,000
Q4 2022

Jan 27, 2023

BUY
$321.55 - $374.67 $32,155 - $37,467
100 Added 526.32%
119 $43,000
Q2 2022

Aug 04, 2022

SELL
$278.73 - $327.27 $68,288 - $80,181
-245 Reduced 92.8%
19 $6,000
Q4 2021

Feb 02, 2022

SELL
$224.85 - $279.04 $2,023 - $2,511
-9 Reduced 3.3%
264 $73,000
Q3 2021

Nov 04, 2021

BUY
$221.6 - $272.71 $6,204 - $7,635
28 Added 11.43%
273 $63,000
Q2 2021

Jul 16, 2021

BUY
$180.55 - $233.54 $44,234 - $57,217
245 New
245 $56,000
Q4 2020

Jan 29, 2021

SELL
$130.46 - $172.63 $135,678 - $179,535
-1,040 Closed
0 $0
Q3 2020

Oct 13, 2020

BUY
$146.22 - $169.13 $73,110 - $84,565
500 Added 92.59%
1,040 $92,000
Q1 2019

May 06, 2019

BUY
$111.31 - $131.02 $60,107 - $70,750
540 New
540 $70,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Riggs Asset Managment Co. Inc. Portfolio

Follow Riggs Asset Managment Co. Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riggs Asset Managment Co. Inc., based on Form 13F filings with the SEC.

News

Stay updated on Riggs Asset Managment Co. Inc. with notifications on news.